Literature DB >> 33186147

Assessment of myocardial function by two-dimensional speckle tracking echocardiography in patients with Kawasaki disease: a mid-term follow-up study.

Haiyong Wang1, Minghui Tong2, Jingjing Mu1, Tingting Wu2, Litao Ruan1.   

Abstract

BACKGROUND: Myocardial impairment proved by histological studies persists in late convalescent phase Kawasaki disease patients. Whether Kawasaki disease-induced myocardial lesions can be detected in an earlier time is not well explored. In this study, we aimed to evaluate left ventricular (LV) myocardial function by two dimensional speckle tracking echocardiography (2DSTE) in late convalescent phase Kawasaki disease patients.
METHODS: A total of 68 Kawasaki disease patients during mid-term phase including 47 with no coronary artery aneurysm (NCAA) and 21 with coronary artery aneurysm (CAA), and 60 controls with age matched were consecutively enrolled.
RESULTS: No significant differences on conventional echocardiographic LV systolic function indices were found among group comparison. Compared with controls, Kawasaki disease patients had lower global longitudinal stain (GLS) and global circumferential stain (GCS). In subgroup analysis, both those with CAA and without CAA had lower GLS, lower GCS, higher amino-terminal propeptide of type III procollagen (PIIINP) and higher carboxyterminal propeptide of procollagen type I (PIPC) than in controls. GLS had significantly negative correlations with PIIINP (r = -0.69, P = 0.002) and PIPC (r = -0.82, P = 0.000).
CONCLUSION: Subclinical myocardial dysfunction in mid-term follow-up Kawasaki disease patients existed regardless of coronary artery status despite normal measurements of LV systolic function by routine echocardiography, and myocardial fibrosis may play a contributed role in this subclinical myocardial function impairment. 2DSTE is a valuable imaging modality for detecting regional and global myocardial dysfunction in Kawasaki disease patients in an early time.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33186147     DOI: 10.1097/MCA.0000000000000981

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  3 in total

1.  Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial.

Authors:  Francesco Pelliccia; Cesare Greco; Gaetano Tanzilli; Nicola Viceconte; Michele Schiariti; Carlo Gaudio
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 2.300

2.  Application Effect and Evaluation of Two-Dimensional Speckle Tracking Imaging on Myocardial Damage in Patients with Malignant Lymphoma Treated with Anthracyclines.

Authors:  Chunqiang Bai; Fanyue Meng; Peiming Feng; Wan Wang; Liang Fang; Qiankun Chang; Lihong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-19       Impact factor: 2.629

3.  Intimal thickening and disruption of the media occur in the arterial walls of coronary arteries not associated with coronary arterial aneurysms in patients with Kawasaki disease.

Authors:  Tomoya Tsuchihashi; Nobuyuki Kakimoto; Takashi Takeuchi; Tomohiro Suenaga; Takayuki Suzuki; Shoichi Shibuta; Yasushi Ino; Takashi Kubo; Takashi Akasaka; Hiroyuki Suzuki
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.